8th Annual Diversity, Inclusion, & Health Equity Symposium
LEADING SYMPOSIUM DISCUSSING EQUITY IN THE HEALTH SECTOR
Chicago, IL, USA
Chicago, IL, USA
The 8th annual Diversity, Inclusion, & Health Equity Symposium is a leading annual, collaborative event focusing on health equity and health disparities in the U.S. The symposium brings together leading healthcare professionals, executives, physicians, patient groups, patients, researchers, academics, clinical trial professionals, and diversity and inclusion advocates to discuss health equity in the life sciences and the health sectors. The symposium focuses on the latest trends, challenges, opportunities in both the marketplace and workplace, with a specific focus on how to best serve an increasingly diverse patient base. We also aim to address the broader health disparity challenges in the U.S., and the symposium equips attendees with the latest insights and ideas. Attendees will learn practical solutions, share perspectives, and meet new industry and marketplace colleagues.
the world’s #1 symposium focusing specifically on health equity and diversity
clinical trials obstacles and how to make the clinical trial ecosystem more diverse and inclusive for all patients
knowledge on how to reduce health disparities by building culturally competent organizations best suited to provide care for diverse patient populations
on building inclusive organizational cultures that attracts the best and brightest people, resulting in a diverse and innovative workforce
how to strategically reduce health disparities to create a more equitable U.S. healthcare system
a workplace that embraces and promotes an inclusive environment by leveraging the latest D&I trends and ideas
to leverage a more diverse marketplace and a more inclusive workforce to create bottom line growth opportunities
and share ideas with many of the country’s leading health sector professionals who are passionate about health equity and diversity
Dr. Copeland is senior vice president of National Diversity and Inclusion strategy and policy and chief Diversity and Inclusion officer for Kaiser Permanente.
Dr. Copeland is a member of Kaiser Permanente’s Executive Diversity and Inclusion Council, a group composed of the chairman/CEO and other C-level leaders who oversee executive accountability for embedding the diversity and inclusion strategy throughout the organization. Additionally, he is chair of the Kaiser Permanente National Diversity and Inclusion Council, which develops and implements the diversity and inclusion strategy and policy recommendations.
A board-certified general surgeon, Dr. Copeland joined Kaiser Permanente in 1988 after a six-year honorable tour of duty in the United States Air Force Medical Corps. Prior to his current role, Dr. Copeland served as president and executive medical director of the Ohio Permanente Medical Group. The Rochester, N.Y., native earned his bachelor’s
degree from Dartmouth College and his medical degree from University of Cincinnati Medical College. He completed his residency in general surgery at State University of New York Upstate Medical Center in Syracuse. He also attended the Advanced Management Program at Harvard Business School.
Currently, Dr. Copeland is a member of the Council of U.S. Diversity and Inclusion Executives of The Conference Board; a fellow of The American College of Surgeons; a member of the advisory panel for Patient-Centered Outcomes Research Institute; a member of the advisory board of Talent Management Alliance; a member of Advancing Women Executives; a board member of the National Organization on Disability; a committee member of the National Quality Forum Disparities Standing Committee; and a member of True Blue Inclusion. In January 2016, Becker’s Hospital Review recognized Dr. Copeland as one of “15 hospital and health systems chief diversity officers to know.”
Ms. Tammy Russo, MS, is VP, Advocacy Relations Practice Lead at Continuum Clinical. Leveraging successful roles in healthcare marketing, integrated communications, medical education and public relations, Tammy created advocacy offerings at three pharmaceutical companies and a healthcare communications agency. She is adept in identifying and collaborating with key patient groups to develop symbiotic initiatives. Included in her experience is development of diversity and inclusion programming to ensure disproportionately impacted populations receive resonant messaging, via appropriate language and mediums. Tammy has lead unbranded educational patient advocacy outreach campaigns, translating messaging into language that resonates with patients, caregivers and healthcare professionals, communicating to the community at large about the implications and impact on treatment decisions, patient empowerment and healthcare reform.
The Mathewson Group
Mr. John Mathewson, MS, is CEO & Managing Member of The Mathewson Group. He provides major strategy advisory, interim executive staffing, and business management support to healthcare organizations and government. His clients include health plans, hospitals, government, ACO’s, FQHC’s, PCA’s and tech/digital health companies. John’s career spans public, private, start up and non-profit companies in government and commercial business. He has opened markets, created companies, leveraged technology, restructured operations, and served as a national thought leader on managing populations with complex needs and disabilities. John earned his Master of Health Services Administration from the George Washington University.
American Heart Association
Ms. Pamela Garmon Johnson, MBA, is National Vice-President of Health Equity and Multicultural Initiatives at American Heart Association, where she is responsible for driving positive health impact within communities that are at greatest risk for cardiovascular diseases. Pamela has served in several capacities and has focused the first half of her career at the AHA in launching and managing corporately sponsored campaigns. Power To End Stroke, Take Wellness To Heart, Cholesterol Low Down, Heart of Diabetes and Walking for Wellness were launched under Pamela’s tenure with the American Heart Association. All of these are award-winning campaigns and have focused on primary prevention and awareness. Pamela has 20 years of accounting and marketing experience and is passionate about empowering others to be their best self. Pamela received her BS in Accounting from the University of North Texas and her MBA from Southern Methodist University.
GE Healthcare Camden Group
Dr. David DiLoreto, MD, MBA, Senior Vice President at GE Healthcare Camden Group, is a physician-executive who is highly experienced in executive management, strategy and operations of healthcare delivery systems, and managed care companies. He has deep management expertise in community-based and academic health systems, large group medical practices, hospitals, and managed care organizations. Prior to joining GE Healthcare Camden Group, Dr. DiLoreto was the Chief Clinical Officer at Presence Health. Dr. DiLoreto is a board-certified ophthalmologist and a graduate of the University of Florida College of Medicine. He holds a master’s degree in business administration Emory University, in Atlanta, Georgia. He earned his bachelor of science degree from Loyola University in New Orleans, Louisiana.
Dr. Melva Covington, PhD, MPH, MBA, is Senior Director, Health Outcomes & Value Assessment at Pacira Pharmaceuticals. Prior to joining Pacira, Dr. Covington is a leader within Global Research and Development at Sanofi. Her leadership skills, expertise and impact has spanned throughout the drug development lifecycle process for over 15 years. She has a broad background in health services research and applies critical thinking, business management and scientific innovation strategically to address complex issues within the healthcare community. Her goal is to apply knowledge contextually to understand the patterns of health care conditions in society as well as more targeted so as to focus on the specific needs of individuals and diverse communities. She has MPH and PhD from the University of North Carolina and MBA from Cornell University. Dr. Covington has authored numerous publications and is an impassioned public speaker. Much of her work focuses on addressing population-based disparities in health outcomes and cultural competency.
Mr. Bert Bruce, MBA, is Vice President, Global Marketing, Rare Disease at Pfizer. His responsibilities span drug development, business development, commercial preparedness and lifecycle management for development and commercialized Rare Disease medicines. Bert has a diverse skill set and broad pharmaceutical background, with leadership experiences across multiple therapeutics areas and disciplines and Johnson & Johnson, Wyeth and Pfizer. Bert earned a B.S. from Eastern College and an M.B.A. from the University of Pennsylvania’s Wharton School of Business. He is well recognized for his strategic vision, collaborative leadership, influencing skills, and development of high-performing teams; his professional passions include improving the participation of minorities in clinical trials and leadership development.
Ms. Dima Elissa, MBA, is the CEO and founder of VisMed-3D, a medical 3D printing company. She is also the Diversity, Inclusion, and Innovation (D & I2) – Tech & Innovation Lead at American Medical Women’s Association. As an adjunct faculty member teaching Entrepreneurship at the Associated Colleges of the Midwest in Chicago and in-demand speaker, she exemplifies her commitment to giving back and paying it forward. She currently serves on the boards of mHUB Chicago, BWG Strategy LLC, Ms. Tech, Women in Bio, Galvanize Labs, and is on the STEM steering committee for the Aparecio Foundation, which provides mentoring to high-achieving, low- income female high school students. Dima holds a B.A. in Chemistry from Hanover College, and earned her MBA from Texas A&M’s May’s School of Business with a concentration in Finance.
191 N. Wacker Drive | Suite 3700
Chicago, IL, USA 60606
Please contact us with any symposium questions.